Somapacitan-beco Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with somapacitan-beco
U
- U-Tri-Lone (triamcinolone)
- UAD Caine (lidocaine)
- Ubrelvy (ubrogepant)
- ubrogepant
- Uceris (budesonide)
- ulipristal
- Ultracet (acetaminophen / tramadol)
- Ultram (tramadol)
- Ultram ER (tramadol)
- Ultram ODT (tramadol)
- Uni Multihist DM (brompheniramine / dextromethorphan / phenylpropanolamine)
- Uni Tuss HC (chlorpheniramine / hydrocodone / phenylephrine)
- Uni Tussin CF (dextromethorphan / guaifenesin / phenylpropanolamine)
- Uni-Cof (chlorpheniramine / dihydrocodeine / pseudoephedrine)
- Uni-Cof Expectorant (dihydrocodeine / guaifenesin / pseudoephedrine)
- Uni-Hist DM Pediatric Drops (brompheniramine / dextromethorphan / pseudoephedrine)
- Uni-Hist DM Pediatric Syrup (brompheniramine / dextromethorphan / guaifenesin / pseudoephedrine)
- Uni-Hist PDX Drops (brompheniramine / dextromethorphan / pseudoephedrine)
- Uni-Hist PDX Syrup (brompheniramine / dextromethorphan / guaifenesin / phenylephrine)
- Uni-Lev 5.0 (guaifenesin / hydrocodone / phenylephrine)
- Uni-Tricof HC (chlorpheniramine / hydrocodone / phenylephrine)
- Uni-Tuss DM (chlorpheniramine / dextromethorphan / phenylephrine)
- upadacitinib
- Urotrol (oxybutynin)
- Utibron Neohaler (glycopyrrolate / indacaterol)
More about somapacitan-beco
- somapacitan-beco consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: growth hormones
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.